Cleared Special

PhantomMSK Hip (K210136) - FDA 510(k) Clearance

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2021
Decision
30d
Days
Class 2
Risk

K210136 is an FDA 510(k) clearance for the PhantomMSK Hip. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by OrthoGrid Systems, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on February 18, 2021 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Incremental AI imaging tool. Low regulatory complexity profile. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all OrthoGrid Systems, Inc. devices

Submission Details

510(k) Number K210136 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 19, 2021
Decision Date February 18, 2021
Days to Decision 30 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 107d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 819
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K210136.
NinesMeasure
K202990 · Nines, Inc. · Feb 2021
MyPAO Planning Report
K200589 · Medacta International S.A. · Feb 2021
TruPlan
K202212 · Circle Cardiovascular Imaging, Inc. · Feb 2021
Vitrea Software Package, VSTP-001A
K203312 · Canon Medical Systems Corporation · Feb 2021
Synapse 3D, Synapse 3D Base Tools v6.1
K203103 · Fujifilm Corporation · Feb 2021
Bonelogic
K203290 · Disior, Ltd. · Feb 2021